Kyverna reports first use of KYV-101 for multiple sclerosis treatment

Kyverna reports first use of KYV-101 for multiple sclerosis treatment

Submitted by admin on April 2, 2024 - 11:27am
Source: 
Clinical Trials Arena
News Tags: 
Kyverna Therapeutics
KYV-101
multiple sclerosis
Headline: 
Kyverna reports first use of KYV-101 for multiple sclerosis treatment
snippet: 

Kyverna Therapeutics has published a report detailing the first-in-disease use of KYV-101 in patients with progressive multiple sclerosis (MS) under a named patient program in Germany.

Do Not Allow Advertisers to Use My Personal information